Style | Citing Format |
---|---|
MLA | Najafabadi FF, et al.. "Intravitreal Bevacizumab for Management of Choroidal Osteoma Without Choroidal Neovascularization." Journal of Ophthalmic and Vision Research, vol. 10, no. 4, 2015, pp. 484-486. |
APA | Najafabadi FF, Hendimarjan S, Zarrin Y, Najafabadi MF (2015). Intravitreal Bevacizumab for Management of Choroidal Osteoma Without Choroidal Neovascularization. Journal of Ophthalmic and Vision Research, 10(4), 484-486. |
Chicago | Najafabadi FF, Hendimarjan S, Zarrin Y, Najafabadi MF. "Intravitreal Bevacizumab for Management of Choroidal Osteoma Without Choroidal Neovascularization." Journal of Ophthalmic and Vision Research 10, no. 4 (2015): 484-486. |
Harvard | Najafabadi FF et al. (2015) 'Intravitreal Bevacizumab for Management of Choroidal Osteoma Without Choroidal Neovascularization', Journal of Ophthalmic and Vision Research, 10(4), pp. 484-486. |
Vancouver | Najafabadi FF, Hendimarjan S, Zarrin Y, Najafabadi MF. Intravitreal Bevacizumab for Management of Choroidal Osteoma Without Choroidal Neovascularization. Journal of Ophthalmic and Vision Research. 2015;10(4):484-486. |
BibTex | @article{ author = {Najafabadi FF and Hendimarjan S and Zarrin Y and Najafabadi MF}, title = {Intravitreal Bevacizumab for Management of Choroidal Osteoma Without Choroidal Neovascularization}, journal = {Journal of Ophthalmic and Vision Research}, volume = {10}, number = {4}, pages = {484-486}, year = {2015} } |
RIS | TY - JOUR AU - Najafabadi FF AU - Hendimarjan S AU - Zarrin Y AU - Najafabadi MF TI - Intravitreal Bevacizumab for Management of Choroidal Osteoma Without Choroidal Neovascularization JO - Journal of Ophthalmic and Vision Research VL - 10 IS - 4 SP - 484 EP - 486 PY - 2015 ER - |